Biopolym. Cell. 2013; 29(1):64-69.
http://dx.doi.org/10.7124/bc.000807
Molecular Biomedicine
Interferon titer and the 2',5'-oligoadenylate-synthetase activity in rat thymus lymphocytes in conditions of Omeprazol-caused hypergastrinemia
1Kompanets I. V., 1Korotkiy O. G., 1Karpovets T. P., 1Pilipenko S. V., 1Nikolska V. V., 1Ostapchenko L. I., 1Yankovsky D. S.
  1. Educational and Scientific Center "Institute of Biology",
    Taras Shevchenko National University of Kyiv
    64/13, Volodymyrska Str., Kyiv, Ukraine, 01601

Abstract

The aim of this work was the determination of rat thymocytes response to hypergastrinemia evoked by hypoacidity and multiprobiotic «Symbiter® acidophilic concentrated» (symbiter) treatment via the estimation of the interferon (IFN) titer and 2', 5'-oligoadenylate (OA)-synthetase activity in lymphocytes. 2', 5'-OA-synthetase is the IFN-induced enzyme. Methods. The micromethod of IFN titer determination by antiviral activity, spectrophotometrical method of 2', 5'-OA-synthetase activity determination. Results. It was shown that the IFN production by cultivated thymocytes is amplified while the 2', 5'-OA-synthetase activity decreases in these cells in conditions of hypoacidity caused by the 28-days omeprazol treatment. The treatment of animals by symbiter against a background of hypoacidity causes the augmentation of IFN production by thymocytes, but does not stimulate the 2', 5'-OA-synthetase activity. The IFN production by thymocytes in response to IFN inducers (PHA and cycloferone) in vitro is intensified comparatively to the control at hypoacidity and symbiter treatment. Conclusions. The multiprobiotic symbiter exhibits interferonogenic properties. The IFN synthesis in response to induction in vitro is intensified in comparison with healthy animals at both hypoacidity and symbiter treatment while the 2', 5'-OA-synthetase acivity in thymocytes decreases.
Keywords: interferon, 2', 5'-oligoadenylate-synthetase, thymocy- tes, omeprazol, hypergastrinemia, probiotics
Full text: (PDF, in Ukrainian)

References

[1] Sen G. C., Sarkar S. N. The interferon-stimulated genes: targets of direct signaling by interferons, double-stranded RNA and viruses Curr. Top. Microbiol. Immunol 2007 316:233–250.
[2] Takaoka A., Yanai H. Interferon signalling network in innate defence Cell. Microbiol 2006 8, N 6:907–922.
[3] Sadler A. J., Williams B. R. Interferon-inducible antiviral effectors Nat. Rev. Immunol 2008 8, N 7:559–568.
[4] Hovanessian A. G. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2'-5'oligoadenylate synthetases and the protein kinase PKR Cytokine Growth Factor Rev 2007 18, N 5–6:351–361.
[5] Lee P. Y., Li Y., Kumagai Y., Xu Y., Weinstein J. S., Kellner E. S., Nacionales D. C., Butfiloski E. J., van Rooijen N., Akira S., Sobel E. S., Satoh M., Reeves W. H. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation Am. J. Pathol 2009 175, N 5:2023–2033.
[6] Fossmark R., Qvigstad G., Waldum H. L. Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia World J. Gastroenterol 2008 14, N 11:1646–1651.
[7] Vesper B. J., Jawdi A., Altman K. W., Haines G. K., Tao L., Radosevich J. A. The effect of proton pump inhibitors on the human microbiota Curr. Drug Metab 2009 10, N 1:84–89.
[8] Zavros Y., Kao J. Y., Merchant J. L. Inflammation and cancer III. Somatostatin and the innate immune system Am. J. Physiol. Gastrointest. Liver Physiol 2004 286, N 5:698–701.
[9] Waldum H. L., Brenna E., Sandvik A. K. Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections Expert. Opin. Drug Saf 2002 1, N 1:29–38.
[10] Uematsu S., Akira S. Toll-like receptors and type I interferons J. Biol. Chem 2007 282, N 21:15319–15323.
[11] Isolauri E., Sutas Y., Kankaanpaa P., Arvilommi H., Salminen S. Probiotics: effects on immunity Am. J. Clin. Nutr 2001 73, 2 Suppl 444S–450S.
[12] Korotkiy O., Pilipenko S., Tsyryuk O., Ostapchenko L., Beregova T. The influence of multiprobiotics on the interferon-gamma level in the blood serum in the rats in conditions of long-term hypoacidity Bulletin of Taras Shevchenko National University of Kyiv,Series: Biology 2009 N 54:47–49.
[13] Jain R. N., Al-Menhali A. A., Keeley T. M., Ross T. S., Chew C. S., Samuelson L. S. Hypergastrinemia and hypertrophic gastritis in Hip1r-deficient mice FASEB J 2007 21:925.4.
[14] Korotkiy O. G., Karpovets T. P., Pilipenko S. V., Beregova T. V., Ostapchenko L. I. Concentration of tumor necrosis factor alpha in rat serum on the background of long-term hypoacidity in conditions of multiprobitics introduction Medical Chemistry 2009 11, N 4:89–91.
[15] Morozov VG, Havinson VH. Immunological function of thymus. Usp Sovrem Biol. 1985; 97(1):36-7.
[16] Stewart W. E. Interferon system New York: Springer, 1979 421 p.
[17] Mechti N., Affabris E., Romeo G., Lebleu B., Rossi G. B. Role of interferon and 2',5'-oligoadenylate synthetase in erythroid differentiation of Friend leukemia cells. Studies with interferon-sensitive and -resistant variants J. Biol. Chem 1984 259, N 5:3261–3265.
[18] Chebath J., Benech P., Hovanessian A.,Galabru J., Revel M. Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells J. Biol. Chem 1987 262, N 8:3852–3857.
[19] Justesen J., Kjeldgaard N. O. Spectrophotometric pyrophosphate assay of 2',5'-oligoadenylate synthetase Anal. Biochem 1992 207, N 1;90–93.
[20] Shono N. I., Baskaeva E. M. Bradford’s method of determining protein: application, advantages and disadvantages Lab. Delo 1989 4:4–7.
[21] Tsyryuk O., Beregova T. An influence of omeprazol-caused hypergastrinemia on rat basal tgastric secretion Bulletin of Biology and Medicine Problems 2007 3:38–43.
[22] Korotkiy O. G., Pilipenko S. V., Kompanets I. V., Ostapchenko L. I. Reaction of lymphoid organs on injection of multiprobiotic «Symbiter® Acidophilic concentrated» on the background of long-term decrease of gastric acid secretion Bulletin of Biology and Medicine Problems 2010 Vyp. 3:55–61.
[23] Alvarez A., Ibiza M. S., Andrade M. M., Blas-Garcia A., Calatayud S. Gastric antisecretory drugs induce leukocyte-endothelial cell interactions through gastrin release and activation of CCK-2 receptors J. Pharmacol. Exp. Ther 2007 323, N 1:406–413.
[24] Capodicasa E., Cornacchione P., Natalini B., Bartoli A., Coaccioli S., Marconi P., Scaringi L. Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes Int. J. Immunopathol. Pharmacol 2008 21, N 1 P 73–85.
[25] Konturek P. C., Kania J., Konturek J. W., Nikiforuk A., Konturek S. J., Hahn E. G. H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis Med. Sci. Monit 2003 9, N 7 SR53–66.